Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
BMJ. 2021 Jan 13;372:m4573. doi: 10.1136/bmj.m4573.
BMJ. 2021.
PMID: 33441402
Free PMC article.